Jason Turner Email & Phone Number

Watford, Hertfordshire, Gb

Lead sales and marketing teams to drive above market growth for Advanced Wound Management (AWM) in Australia and New Zealand (ANZ).Developed strategic plans to increase revenue and market share for Smith+Nephew in the ANZ region.Implemented innovative marketing campaigns to promote AWM products and services effectively.Full P&L Responsibility.

Watford, Hertfordshire, Gb

Finance Lead for ANZ Business, partnering with leadership team to deliver on financial expectations. Company Director.

Basel, Basel-Stadt, Ch

• Responsible for Sales and Marketing functions of Sandoz Australia Generic medicine & OTC• Responsible for Sandoz New Zealand Business.• P&L responsibility for > $200m AUD business.Built a stable high performing team through investing in strong training and development, structured learnings and regular coaching and mentoring. Improving culture thus imbedding a collaborative culture.Lead a high performing team of 34 across multiple functions including Marketing, Sales Force Effectiveness, Retail Sales, Hospital Sales for generics medicines and OTC.Achieved all top and bottom line targets which had been increased on prior year. In 2018 overachieved stretched targets by greater than 5% culminating in the entire company having an incentive trip to Fiji in 2019.Upgraded and enhanced the existing Veeva (salesforce) platform and the data warehouse analytical system. This allowed for further improved key account management and identifying where the major opportunities were and shared data with the major key accounts to allow them to improve their business. We also tightened up the use of analytical data around segmenting customers to allow for a more targeted sales and account management approach, particularly at launch of products.Re-signed major key account customers for long term contracts through developing strong relationships with the key stakeholders and becoming a trusted partner.

Basel, Basel-Stadt, Ch

• Responsible for Retail Pharmacy and Hospital sales teams.Achieved all top and bottom line targets making up for $8 Million lost sales in the prior year, As well as all other KPI’s. with outcomes coming predominantly from existing customers (95%) and the balance from new accounts.Restructured the existing sales team and brought in 6-7 new team members which upskilled the team and created a solid base which was able to move forward successfully. Built a strong and diverse team.Obtained greater uptakes of products which had been launched prior but had sub optimal penetration. Extended the range and new SKUs with a greater commitment from key customers.Retained and grew customer numbers.Was a member of a number of working groups with the industry body, GBMA (Generic and Biosimilars Medical Association).

Basel, Basel-Stadt, Ch

• Responsible for CFO duties of Sandoz AUNZ. Played a key role in turning the business around to be more profitable and future ready.Heavily involved in turning business around to hit all top and bottom-line targets.Joined the business following an $18Million correction of incorrectly created accruals and prepared the business for a detailed internal audit. Led the team through the audit process and achieved a successful audit result having driven the correction of the business processes in preparation for the audit. Built a strong system and processes to ensure accuracy of rebate / discount accrual and payments.Initiated a closer working alliance by personally visiting key customers either with the sales team or separately which enabled much more effective discussions on matters which were critical to the account and this constant profile created a much stronger relationship between the business.Worked with a number of large accounts to identify the key products to focus on which will grow their business and profit but would also drive the Sandoz business and profit. Working closely with key customers on key projects maximising returns for both Sandoz and the customer and created trusted long-term partnerships.Part of a number of working groups with the industry body, particularly covering pricing policy with GBMA and was appointed as an alternative director of GBMA. Part of the Generic Medicines Working Group (GMWG) with the Department of Health. Involved in a number of key initiatives;• Achieved an increase the reimbursed price on a large number of medicines to ensure that the new level was at a profitable level for the industry Dec 2016. • Lobbied for changes in how the price review happens going forward which provided greater voice and more sustainable industry, reforms implemented in 2017.2IC to Company General Manager and took on accountability and responsibility when they were out of the country or on leave.

Basel, Baselstadt, Ch

• Responsible for Novartis pharmaceuticals CFO role for Scandinavia (Sweden, Norway, Denmark & Iceland). • Corporate country CFO for Sweden and Norway. Company Director and Director of Novartis Foundation in Sweden.• Lead a large multi-site team of direct and indirect reports.• Managed IT, Procurement and Facilities for Novartis businesses in Scandinavia Integration and completion of a cross divisional shared service function for finance in Scandinavian countries for Pharma, Consumer Health and Animal Health divisions This provided much greater cost efficiency and more streamlined processesIntroduced and drive a key change management piece to ensure that all key deliverables were met on timeImplemented new processes and systems to ensure that all financial and commercial activities were in regulatory compliance and brought the business up to Novartis international standards.Optimised the businesses, scaled back the size of offices and outsourced a number of roles. Set-up of internal controls of the shared service function, (satisfactory internal Audit finding in 2010). Outsourcing financial transactional services to a third-party provider in Romania once new processes stabilised.

Basel, Basel-Stadt, Ch

Integration of Hexal business following global acquisition, bringing Hexal onto SAP system.Following the acquisition of Hexal the management team was made up of Hexal except for CFO the role. Managed project to Redo all policies and procedures for the combined business.Reviewed all the suppliers and renegotiated new supplier contracts with some of the largest pharmaceutical companies as suppliers. Led a number of the key negotiations and involved with all other negotiations as far as signing off on financial documentation.Set up the cross divisional finance function which went live early in 2009. This required;Key in developing a number of commercial offerings in the marketplace for acquiring new customers;Involved in over 10 in licensing / out-licensing deals with local and overseas players, with a financial impact of between $ AUD 5-$60Million on each of the licensing deals. Director and Company Secretary for Sandoz Pty Ltd and Hexal Pty Ltd Australia. Key Member of Executive team.

Basel, Baselstadt, Ch

Basel, Baselstadt, Ch

Macquarie Park, Nsw, Au

Blackfriars, London, Gb

Education record

Accounting

Bsc, Anatomy, Physiology, Biochemistry